Shopping Cart 0
Cart Subtotal
USD 0

University of Wisconsin Madison - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

University of Wisconsin Madison (UW-Madison), a subsidiary of University of Wisconsin System is an educational and research institution that provides undergraduate and postgraduate courses. The institution offers courses in various fields such as agricultural and life sciences, arts, business, engineering, graduate school, law school, nursing, veterinary medicine, public affairs, medicine and public health and library and information studies, among others. It also organizes youth programs such as Badger summer sports camps, PEOPLE Program, Saturday Enrichment, and Summer Science Institute. The institution's research centers include Agribusiness Institute, Antarctic Meteorological Research Center, Aquatic Sciences Center, Biotechnology Center, Cardiovascular Research Center and Environmental Remote Sensing Center, among others. UW-Madison is headquartered in Madison, Wisconsin, the US.

University of Wisconsin Madison-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

University of Wisconsin Madison, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

University of Wisconsin Madison, Medical Devices Deals, 2012 to YTD 2018 10

University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deal Details 13

Venture Financing 13

FluGen Raises USD12 Million in Series A Financing 13

Madison Vaccines Raises Additional USD2 Million in Series A Financing 14

Madison Vaccines Raises USD 8 Million In Series A Financing 15

Partnerships 17

Revive Therapeutics Enters into Research Agreement with University of Wisconsin Madison 17

NanoViricides Expands into Agreement with University of Wisconsin-Madison 18

Janssen Pharma Enters into Agreement with University of Wisconsin-Madison 19

Morphotek Enters into Research Agreement with University of Wisconsin Madison 20

UW Institute for Clinical and Translational Research to Form Partnership with German Center for Neurodegenerative Diseases 21

Licensing Agreements 22

Cellectar Biosciences Enters into Licensing Agreement with Wisconsin Alumni Research Foundation 22

AhR Pharma Enters Into Licensing Agreement With WARF For Cancer Fighting Hormone 23

Cellular Dynamics International Enters into Licensing Agreement with Wisconsin Alumni Research Foundation 24

AllCells Enters Into Licensing Agreement With Wisconsin Alumni Research Foundation And WiCell Research Institute 26

Equity Offering 27

Co-D Therapeutics Spin Off from University of Wisconsin Madison 27

University of Wisconsin Madison-Key Competitors 28

University of Wisconsin Madison-Key Employees 29

University of Wisconsin Madison-Locations And Subsidiaries 30

Head Office 30

Other Locations & Subsidiaries 30

Recent Developments 31

Government and Public Interest 31

Sep 25, 2018: USD 19M grant to aid research on early signs of Alzheimer's 31

Jul 30, 2018: Researchers trace Parkinson's damage in the heart 32

Jul 02, 2018: Study: Zika could cause more miscarriages than we realize 34

Jul 02, 2018: Zika may cause many more miscarriages than previously recognized 35

Jun 18, 2018: Researchers Uncover New Target to Stop Cancer Growth 36

May 08, 2018: Metastasis enablers: Findings could unlock new ovarian cancer treatments 37

Apr 24, 2018: Bacteria boost antifungal drug resistance in severe childhood tooth decay 39

Jan 23, 2018: Damon Runyon Cancer Research Foundation awards USD 3M to eleven innovative early career scientists 41

Jan 16, 2018: Study advances gene therapy for glaucoma 44

Oct 23, 2017: New study shows how cells can be led down non-cancer path 46

Aug 10, 2017: New measure of insulin-making cells could gauge diabetes progression, treatment 47

Jul 14, 2017: Advance furthers stem cells for use in drug discovery, cell therapy 48

Jun 27, 2017: Morgridge scientists illuminate structures vital to virus replication 49

Product News 51

Jan 24, 2017: Watching gene editing at work to develop precision therapies 51

Other Significant Developments 52

Jun 27, 2018: LGR6+ Cells And Defensin Peptides Deliver A New, Targeted Avenue For Treating Skin Aging 52

Appendix 53

Methodology 53

About GlobalData 53

Contact Us 53

Disclaimer 53


List Of Figure

List of Figures

University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

University of Wisconsin Madison, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

University of Wisconsin Madison, Pharmaceuticals & Healthcare, Key Facts 2

University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

University of Wisconsin Madison, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

University of Wisconsin Madison, Deals By Therapy Area, 2012 to YTD 2018 9

University of Wisconsin Madison, Medical Devices Deals, 2012 to YTD 2018 10

University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

FluGen Raises USD12 Million in Series A Financing 13

Madison Vaccines Raises Additional USD2 Million in Series A Financing 14

Madison Vaccines Raises USD 8 Million In Series A Financing 15

Revive Therapeutics Enters into Research Agreement with University of Wisconsin Madison 17

NanoViricides Expands into Agreement with University of Wisconsin-Madison 18

Janssen Pharma Enters into Agreement with University of Wisconsin-Madison 19

Morphotek Enters into Research Agreement with University of Wisconsin Madison 20

UW Institute for Clinical and Translational Research to Form Partnership with German Center for Neurodegenerative Diseases 21

Cellectar Biosciences Enters into Licensing Agreement with Wisconsin Alumni Research Foundation 22

AhR Pharma Enters Into Licensing Agreement With WARF For Cancer Fighting Hormone 23

Cellular Dynamics International Enters into Licensing Agreement with Wisconsin Alumni Research Foundation 24

AllCells Enters Into Licensing Agreement With Wisconsin Alumni Research Foundation And WiCell Research Institute 26

Co-D Therapeutics Spin Off from University of Wisconsin Madison 27

University of Wisconsin Madison, Key Competitors 28

University of Wisconsin Madison, Key Employees 29

University of Wisconsin Madison, Subsidiaries 30

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

University of Wisconsin Madison, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.